NASA, GM Jointly Developing Robotic Gloves For Human Use
HOUSTON, March 13, 2012 /PRNewswire-USNewswire/ -- NASA and General Motors are jointly developing a robotic glove that astronauts and autoworkers can wear to help do their respective jobs better while potentially reducing the risk of repetitive stress injuries.

House Building Robots, Traffic Avoidance System, Personalized Drug Dosing, Bone and Tissue Repair Gel, and Improved Diagnostic Techniques Represent 20
Six high potential USC startups complete Phase I and receive $498,700 in proof of concept funding. LOS ANGELES, March 7, 2012 /PRNewswire-USNewswire/ -- Stevens Institute for Innovation today announced that six innovative ideas have advanced through phase I of the Ideas Empowered Program and have received $498,700 to advance their high impact research to the next stage of development and investment.  31 proposals were submitted in the summer of 2011 and a prestigious review panel of more than 50 members of the LA business and academic community chose nine finalists to participate in Phase I of the program.

Avanir Pharmaceuticals and Concert Pharmaceuticals Announce License Agreement to Develop and Commercialize Deuterium-modified Dextromethorphan for Dis
ALISO VIEJO, Calif. and LEXINGTON, Mass., Feb. 29, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (Nasdaq: AVNR) and Concert Pharmaceuticals, Inc. announced today that they have entered into an exclusive license agreement that provides Avanir worldwide rights to develop and commercialize Concert's deuterium-modified dextromethorphan (d-DM) for the potential treatment of neurological and psychiatric disorders.  The agreement includes the rights to multiple deuterium-modified dextromethorphan compounds. Under the terms of the agreement, Concert will receive an upfront payment and is eligible to receive additional milestone payments upon achievement of certain predefined clinical, regulatory and commercial targets as well as tiered royal ...